BSEM Projected Dividend Yield

Biostem Technologies Inc ( OTCBB : BSEM )

Biostem Technologies is engaged in providing goods and services that use stem cell research, nutraceutical and telomere science to promote antiaging, examine life extension possibilities, and defeat disease. Co.'s subsidiaries under which it operates its business include: Biostem Wellness, Inc., which develops and markets nutraceutical products as well as other nonproprietary products; Biostem Pharmaceuticals, Inc., which provides pharmaceutical research and development; BIO ST Holdings S de R.L. de CV, which provides cell based therapies to customers; and Quality Pharma Ingredients Inc., which is engaged in repackaging and distribution of active pharmaceutical ingredients.

20 YEAR PERFORMANCE RESULTS